Suchergebnisse - "Li, Yilin"

PubPharm (5)

1

Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients

enthalten in: Cancer letters | 2021

von Chen, Y. | Li, Y. | Qi, C. | +15

2

PD-L1+ aneuploid circulating tumor endothelial cells (CTECs) exhibit resistance to the checkpoint blockade immunotherapy in advanced NSCLC patients

enthalten in: Cancer letters | 2020

von Zhang, L. | Zhang, X. | Liu, Y. | +7

3

Quantified postsurgical small cell size CTCs and EpCAM+ circulating tumor stem cells with cytogenetic abnormalities in hepatocellular carcinoma patients determine cancer relapse

enthalten in: Cancer letters | 2018

von Wang, L. | Li, Y. | Xu, J. | +10

4

The anti-HER3 antibody in combination with trastuzumab exerts synergistic antitumor activity in HER2-positive gastric cancer

enthalten in: Cancer letters | 2016

von Wang, Q. | Zhang, X. | Shen, E. | +9

5

The anti-HER3 antibody in combination with trastuzumab exerts synergistic antitumor activity in HER2-positive gastric cancer

enthalten in: Cancer letters | 2016

von Wang, Q. | Zhang, X. | Shen, E. | +9

1
[1]